Skip to main content
SpringerLink
Log in

HIV-associated bodyweight loss: a therapeutic challenge

  • New Drugs and Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Stosor V, Von Roenn J. Therapeutic options for HIV-associated bodyweight loss: a risk-benefit analysis. Drug Saf 1997; 17(5): 290–302

    Article  PubMed  CAS  Google Scholar 

  2. Nahlen BL, Chu SY, Nwanyanwu OC, et al. HIV wasting syndrome in the United States. AIDS 1993; 7: 183–8

    Article  PubMed  CAS  Google Scholar 

  3. Palenicek JP, Graham NMH, He YD, and the MACS Investigators. Weight loss prior to clinical AIDS as a predictor of survival. J Acquir Immune Defic Syndr 1995; 10: 366–73

    CAS  Google Scholar 

  4. Guenter P, Muurahainen N, Simons G, et al. Relationships among nutritional status, disease progression, and survival in HIV infection. J Acquir Immune Defic Syndr 1993; 6: 1130–8

    PubMed  CAS  Google Scholar 

  5. Kotler DP, Tierney AR, Ferraro R, et al. Enteral alimentation and repletion of body cell mass in malnourished patients with acquired immunodeficiency syndrome. Am J Nutr 1991; 53: 149–54

    CAS  Google Scholar 

  6. Kotler DP, Tierney AR, Culpepper-Morgan, et al. Effect of home parenteral nutrition on body composition in patients with acquired immunodeficiency syndrome. J Parenter Enteral Nutr 1990; 14: 454–8

    Article  CAS  Google Scholar 

  7. Oster M, Enders SR, Samuels SJ, et al. Megestrol acetate in patients with AIDS and cachexia. Ann Intern Med 1994; 121: 400–8

    PubMed  CAS  Google Scholar 

  8. Von Roenn JH, Armstrong D, Kotler DP, et al. Megestrol acetate in patients with AIDS-related cachexia. Ann Intern Med 1994; 121: 393–9

    Google Scholar 

  9. Beal JE, Olson R, Laubenstein L, et al. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symptom Manage 1995; 10: 89–97

    Article  PubMed  CAS  Google Scholar 

  10. Berger JR, Pall L, Hall CD, et al. Oxandrolone in AIDS-wasting myopathy. AIDS 1996; 10: 1657–62

    Article  PubMed  CAS  Google Scholar 

  11. Schambelan M, Mulligan K, Grunfeld C, and the Serostim Study Group. Recombinant human growth hormone in patients with HIV-associated wasting: a randomized, placebo-controlled trial. Ann Intern Med 1996; 125: 873–82

    PubMed  CAS  Google Scholar 

  12. Reyes-Terán G, Sierra-Madero JG, Martínez del Cerro V, et al. Effects of thalidomide on HIV-associated wasting syndrome: a randomized, double-blind placebo-controlled clinical trial. AIDS 1996; 10: 1501–7

    Article  PubMed  Google Scholar 

  13. Struwe M, Kaempfer SH, Geiger CJ, et al. The effect of dronabinol on nutritional status in HIV infection. Ann Pharmacother 1993; 27: 827–31

    PubMed  CAS  Google Scholar 

  14. Gold J, High HA, Li Y, et al. Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection. AIDS 1996; 10: 745–52

    Article  PubMed  CAS  Google Scholar 

  15. Hengge UR, Baumann M, Maleba R, et al. Oxymetholone promotes weight gain in patients with advanced human immunodeficiency (HIV-1) infection. Br J Nutr 1996; 75: 129–38

    Article  PubMed  CAS  Google Scholar 

  16. Waters D, Danska J, Hardy K, et al. Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1996; 125: 865–72

    PubMed  CAS  Google Scholar 

  17. Klausner JD, Makonkawkeyoon S, Akarasewi P, et al. The effect of thalidomide on the pathogenesis of human immunodeficiency virus type I and M. tuberculosis infection. J Acquir Immune Defic Syndr 1996; 11: 247–57

    Article  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

HIV-associated bodyweight loss: a therapeutic challenge. Drugs Ther. Perspect 11, 5–8 (1998). https://doi.org/10.2165/00042310-199811080-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199811080-00003

Keywords

Search

Navigation